Mediastinal Large-Cell Lymphoma with Sclerosis
Author Information
Author(s): A.Z.S. Rohatiner, I.S. Whelan, R.K. Ganjool, A.J. Norton, A. Wilson, T.A. Lister
Primary Institution: St Bartholomew's Hospital, London, UK
Hypothesis
Can patients with mediastinal large-cell lymphoma with sclerosis be effectively treated with chemotherapy?
Conclusion
A proportion of patients with this rare subtype of high-grade B-cell lymphoma may be cured by chemotherapy alone.
Supporting Evidence
- Complete remission was achieved in only 4 out of 22 patients with the initial treatment.
- Overall response rate was 68%, with 15 out of 22 patients showing some degree of response.
- With a median follow-up of 51 years, 10 out of 22 patients remain well without progression.
Takeaway
This study looked at 22 patients with a specific type of lymphoma and found that some could be cured with chemotherapy, even if they had a big tumor at first.
Methodology
Retrospective analysis of 22 patients diagnosed with MLCLS over a 14-year period.
Limitations
The study is based on a small sample size and reflects treatment practices that may have changed over time.
Participant Demographics
Patients aged 19-71, median age 30, with a gender distribution of 10 males and 12 females.
Want to read the original?
Access the complete publication on the publisher's website